3,817 companies
12,975 AI summaries
9,784 risk analyses
5,404 growth scores
Register free — watchlist & alerts →
🔔 Get free email alerts on Daito Pharmaceutical Co., Ltd. (4577)
AI summaries of Japanese EDINET filings — in English. Free, unsubscribe anytime.
- ✓ Email alert when 4577 files its next EDINET disclosure
- ✓ AI summary · sentiment · risk · growth (JA / EN)
- ✓ Free account: watchlist & alerts on all the stocks you follow
EDINET 4577 Out of Scope
Daito Pharmaceutical Co., Ltd.
Change Report ／ 2026-11-10 16:03
Covers EDINET statutory filings (TDNET timely disclosures / earnings flashes are not included).
📊 Large-shareholding (5%) report Pure investment
Holder: Kaname Capital,L.P.
Stake: 12.13%
Change: +1pp increase
Purpose:
Pure investment. If the issuer's market share price remains at a level deemed undervalued, we plan to acquire additional common shares exceeding 5% of total issued shares through market transactions within three months as part of our portfolio investment. However, specific evaluation criteria, acquisition price, quantity, and timing have not been determined.
🧩 5% holders of this company (1 holders · 12.13%)
| Holder | Stake | Change | |
|---|---|---|---|
| Kaname Capital,L.P. Pure | 12.13% | +1pp | view |
Each holder’s most recent 5% filing. The sum reflects disclosed major-holder ownership, not total float.
Risk and growth scores and tags are AI-generated estimates from analyzing the disclosure. They are not guarantees of fact, nor investment advice or recommendations. Make investment decisions at your own discretion.
Track Japanese disclosures with JSIGNAL
AI summaries, risk & growth analysis, watchlist alerts and a screener for every Japanese listed company.
Start free — 30-day trial Login